{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:00:45Z","timestamp":1787760045305,"version":"build-2784847793"},"reference-count":94,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 AI007501 (to M.J.B.)"],"award-info":[{"award-number":["T32 AI007501 (to M.J.B.)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 AI007501 (to M.J.B.)"],"award-info":[{"award-number":["T32 AI007501 (to M.J.B.)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,11,27]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>HIV infection of the CNS causes neuroinflammation and damage that contributes to the development of HIV-associated neurocognitive disorders (HAND) in greater than 50% of HIV-infected individuals, despite antiretroviral therapy (ART). Opioid abuse is a major risk factor for HIV infection. It has been shown that opioids can contribute to increased HIV CNS pathogenesis, in part, by modulating the function of immune cells. HIV enters the CNS within two weeks after peripheral infection by transmigration of infected monocytes across the blood brain barrier (BBB). CD14+CD16+ monocytes are a mature subpopulation that is increased in number in the peripheral blood of HIV-infected people. Mature monocytes can be productively infected with HIV, and they transmigrate preferentially across the BBB in response to CCL2, a chemokine elevated in the CNS and CSF of HIV-infected people even with ART. Buprenorphine, an opioid derivate, is an opioid replacement therapy for heroin addiction. It is a partial agonist of \u03bc-opioid receptor and full antagonist of \u03ba-opioid receptor. The effects of buprenorphine on CCL2-mediated CD14+CD16+ monocytes transmigration across the BBB, a critical mechanism that promotes neuroinflammation and HAND, have not been characterized. We showed for the first time that buprenorphine decreases several steps of CCL2-mediated human mature monocyte transmigration. We propose that buprenorphine treatment in the context of HIV infection could serve a dual purpose, to treat opioid addiction and also to reduce neuroinflammation. Additionally, buprenorphine may be used as a treatment for HAND not only in the context of opioid abuse.<\/jats:p><jats:p>Buprenorphine may decrease neuroinflammation by limiting CCL2-mediated CD14+CD16+ monocytes migration.<\/jats:p>","DOI":"10.1002\/jlb.3hi0118-015r","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T14:16:42Z","timestamp":1527085002000},"page":"1049-1059","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14+CD16+ monocytes"],"prefix":"10.1093","volume":"104","author":[{"given":"Matias","family":"Jaureguiberry-Bravo","sequence":"first","affiliation":[{"name":"Department of Pathology, Albert Einstein College of Medicine , Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillie","family":"Lopez","sequence":"additional","affiliation":[{"name":"Department of Pathology, Albert Einstein College of Medicine , Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan W","family":"Berman","sequence":"additional","affiliation":[{"name":"Department of Pathology, Albert Einstein College of Medicine , Bronx, New York, USA"},{"name":"Department of Microbiology and Immunology, Albert Einstein College of Medicine , Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,23]]},"reference":[{"key":"2023032406065853700_jlb10171-cit-0001","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jis326","article-title":"Central nervous system viral invasion and inflammation during acute HIV infection","volume":"206","author":"Valcour","year":"2012","journal-title":"J Infect Dis"},{"key":"2023032406065853700_jlb10171-cit-0002","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.42.9.1736","article-title":"Early viral brain invasion in iatrogenic human immunodeficiency virus infection","volume":"42","author":"Davis","year":"1992","journal-title":"Neurology"},{"key":"2023032406065853700_jlb10171-cit-0003","doi-asserted-by":"crossref","first-page":"e8129","DOI":"10.1371\/journal.pone.0008129","article-title":"Coordinated regulation of SIV replication and immune responses in the CNS","volume":"4","author":"Witwer","year":"2009","journal-title":"PLoS One"},{"key":"2023032406065853700_jlb10171-cit-0004","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrneurol.2016.53","article-title":"HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"2023032406065853700_jlb10171-cit-0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","article-title":"HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors","volume":"17","author":"Heaton","year":"2011","journal-title":"J Neurovirol"},{"key":"2023032406065853700_jlb10171-cit-0006","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/1570162X12666140526114526","article-title":"Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders","volume":"12","author":"Williams","year":"2014","journal-title":"Curr HIV Res"},{"key":"2023032406065853700_jlb10171-cit-0007","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1523\/JNEUROSCI.3863-05.2006","article-title":"CCL2\/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS","volume":"26","author":"Eugenin","year":"2006","journal-title":"J Neurosci"},{"key":"2023032406065853700_jlb10171-cit-0008","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1080\/135502801753248114","article-title":"CNS invasion by CD14+\/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection","volume":"7","author":"Fischer-Smith","year":"2001","journal-title":"J Neurovirol"},{"key":"2023032406065853700_jlb10171-cit-0009","doi-asserted-by":"crossref","first-page":"e69270","DOI":"10.1371\/journal.pone.0069270","article-title":"Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis","volume":"8","author":"Williams","year":"2013","journal-title":"PLoS One"},{"key":"2023032406065853700_jlb10171-cit-0010","doi-asserted-by":"crossref","first-page":"e1004533","DOI":"10.1371\/journal.ppat.1004533","article-title":"Anti-alpha4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection","volume":"10","author":"Campbell","year":"2014","journal-title":"PLoS Pathog"},{"key":"2023032406065853700_jlb10171-cit-0011","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/QAI.0b013e318256f3bc","article-title":"Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection","volume":"60","author":"Kamat","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2023032406065853700_jlb10171-cit-0012","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s13365-013-0150-5","article-title":"Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China","volume":"19","author":"Yuan","year":"2013","journal-title":"J Neurovirol"},{"key":"2023032406065853700_jlb10171-cit-0013","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MOH.0b013e3283333949","article-title":"New observations on the trafficking and diapedesis of monocytes","volume":"17","author":"Kamei","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"2023032406065853700_jlb10171-cit-0014","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nri1375","article-title":"Adhesion mechanisms regulating the migration of monocytes","volume":"4","author":"Imhof","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"2023032406065853700_jlb10171-cit-0015","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1091\/mbc.10.4.861","article-title":"Specific activation of leukocyte beta2 integrins lymphocyte function-associated antigen-1 and Mac-1 by chemokines mediated by distinct pathways via the alpha subunit cytoplasmic domains","volume":"10","author":"Weber","year":"1999","journal-title":"Mol Biol Cell"},{"key":"2023032406065853700_jlb10171-cit-0016","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1083\/jcb.134.4.1063","article-title":"Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis","volume":"134","author":"Weber","year":"1996","journal-title":"J Cell Biol"},{"key":"2023032406065853700_jlb10171-cit-0017","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1471-4159.2007.05056.x","article-title":"Transcellular transport of CCL2 across brain microvascular endothelial cells","volume":"104","author":"Ge","year":"2008","journal-title":"J Neurochem"},{"key":"2023032406065853700_jlb10171-cit-0018","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/jnen\/62.4.412","article-title":"Regulation and functional effects of monocyte migration across human brain-derived endothelial cells","volume":"62","author":"Seguin","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"2023032406065853700_jlb10171-cit-0019","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.4049\/jimmunol.156.3.1284","article-title":"Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain","volume":"156","author":"Nottet","year":"1996","journal-title":"J Immunol"},{"key":"2023032406065853700_jlb10171-cit-0020","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ni1222","article-title":"Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis","volume":"6","author":"Terashima","year":"2005","journal-title":"Nat Immunol"},{"key":"2023032406065853700_jlb10171-cit-0021","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"key":"2023032406065853700_jlb10171-cit-0022","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1212\/NXI.0000000000000036","article-title":"CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders","volume":"1","author":"Williams","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2023032406065853700_jlb10171-cit-0023","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1189\/jlb.5A0714-347R","article-title":"JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals","volume":"97","author":"Williams","year":"2015","journal-title":"J Leukoc Biol"},{"key":"2023032406065853700_jlb10171-cit-0024","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(96)10178-1","article-title":"Unique monocyte subset in patients with AIDS dementia","volume":"349","author":"Pulliam","year":"1997","journal-title":"Lancet"},{"key":"2023032406065853700_jlb10171-cit-0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1176\/appi.neuropsych.11050109","article-title":"Cognitive performance related to HIV-1-infected monocytes","volume":"24","author":"Kusao","year":"2012","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2023032406065853700_jlb10171-cit-0026","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1172\/JCI115196","article-title":"Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta","volume":"87","author":"Allen","year":"1991","journal-title":"J Clin Invest"},{"key":"2023032406065853700_jlb10171-cit-0027","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1002\/eji.1830251232","article-title":"CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection","volume":"25","author":"Thieblemont","year":"1995","journal-title":"Eur J Immunol"},{"key":"2023032406065853700_jlb10171-cit-0028","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.4049\/jimmunol.178.10.6581","article-title":"The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo","volume":"178","author":"Ellery","year":"2007","journal-title":"J Immunol"},{"key":"2023032406065853700_jlb10171-cit-0029","doi-asserted-by":"crossref","first-page":"e01280","DOI":"10.1128\/mBio.01280-17","article-title":"Mechanisms of CNS viral seeding by HIV(+) CD14(+) CD16(+) monocytes: establishment and reseeding of viral reservoirs contributing to HIV-associated neurocognitive disorders","volume":"8","author":"Veenstra","year":"2017","journal-title":"MBio"},{"key":"2023032406065853700_jlb10171-cit-0030","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1186\/s12889-017-4528-9","article-title":"The risk of HIV transmission at each step of the HIV care continuum among people who inject drugs: a modeling study","volume":"17","author":"Escudero","year":"2017","journal-title":"BMC Public Health"},{"key":"2023032406065853700_jlb10171-cit-0031","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1007\/s10461-017-1736-3","article-title":"Drug use and sexual HIV transmission risk among men who have sex with men and women (MSMW), men who have sex with men only (MSMO), and men who have sex with women only (MSWO) and the female partners of MSMW and MSWO: a network perspective","volume":"21","author":"Dyer","year":"2017","journal-title":"AIDS Behav"},{"key":"2023032406065853700_jlb10171-cit-0032","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2105\/AJPH.84.12.1971","article-title":"The types of drugs used by HIV-infected injection drug users in a multistate surveillance project: implications for intervention","volume":"84","author":"Diaz","year":"1994","journal-title":"Am J Public Health"},{"key":"2023032406065853700_jlb10171-cit-0033","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/jamapsychiatry.2017.0113","article-title":"Changes in US lifetime heroin use and heroin use disorder: prevalence from the 2001\u20132002 to 2012\u20132013 national epidemiologic survey on alcohol and related conditions","volume":"74","author":"Martins","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"2023032406065853700_jlb10171-cit-0034","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"N Engl J Med"},{"key":"2023032406065853700_jlb10171-cit-0035","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annu Rev Public Health"},{"key":"2023032406065853700_jlb10171-cit-0036","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s13365-013-0225-3","article-title":"Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users","volume":"20","author":"Smith","year":"2014","journal-title":"J Neurovirol"},{"key":"2023032406065853700_jlb10171-cit-0037","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11481-006-9018-2","article-title":"Neurobiology of multiple insults: hIV-1-associated brain disorders in those who use illicit drugs","volume":"1","author":"Bell","year":"2006","journal-title":"J Neuroimmune Pharmacol"},{"issue":"Suppl 2","key":"2023032406065853700_jlb10171-cit-0038","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/00126334-200210012-00003","article-title":"HIV and drug misuse in the Edinburgh cohort","volume":"31","author":"Bell","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2023032406065853700_jlb10171-cit-0039","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s11481-011-9272-9","article-title":"Morphine potentiates neuropathogenesis of SIV infection in rhesus macaques","volume":"6","author":"Bokhari","year":"2011","journal-title":"J Neuroimmune Pharmacol"},{"key":"2023032406065853700_jlb10171-cit-0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2174\/1570162X14666160324124132","article-title":"Opioids and opioid maintenance therapies: their impact on monocyte-mediated HIV neuropathogenesis","volume":"14","author":"Jaureguiberry-Bravo","year":"2016","journal-title":"Curr HIV Res"},{"key":"2023032406065853700_jlb10171-cit-0041","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2174\/157016212802138805","article-title":"Mechanism(s) involved in opioid drug abuse modulation of HAND","volume":"10","author":"Dutta","year":"2012","journal-title":"Curr HIV Res"},{"key":"2023032406065853700_jlb10171-cit-0042","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s13365-011-0037-2","article-title":"Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis","volume":"17","author":"Banerjee","year":"2011","journal-title":"J Neurovirol"},{"key":"2023032406065853700_jlb10171-cit-0043","doi-asserted-by":"crossref","first-page":"e2823","DOI":"10.1136\/bmj.e2823","article-title":"Maintenance drugs to treat opioid dependence","volume":"344","author":"Farrell","year":"2012","journal-title":"BMJ"},{"key":"2023032406065853700_jlb10171-cit-0044","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"2023032406065853700_jlb10171-cit-0045","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0028-3908(87)90112-2","article-title":"Buprenorphine has potent kappa opioid receptor antagonist activity","volume":"26","author":"Leander","year":"1987","journal-title":"Neuropharmacology"},{"key":"2023032406065853700_jlb10171-cit-0046","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cellimm.2010.12.004","article-title":"Characterization of monocyte maturation\/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS","volume":"267","author":"Buckner","year":"2011","journal-title":"Cell Immunol"},{"key":"2023032406065853700_jlb10171-cit-0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2050-7771-2-1","article-title":"Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases","volume":"2","author":"Yang","year":"2014","journal-title":"Biomark Res"},{"key":"2023032406065853700_jlb10171-cit-0048","doi-asserted-by":"crossref","first-page":"a021857","DOI":"10.1101\/cshperspect.a021857","article-title":"CSF-1 receptor signaling in myeloid cells","volume":"6","author":"Stanley","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2023032406065853700_jlb10171-cit-0049","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1600-065X.2012.01127.x","article-title":"Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models","volume":"248","author":"Takeshita","year":"2012","journal-title":"Immunol Rev"},{"key":"2023032406065853700_jlb10171-cit-0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/mvre.1995.1028","article-title":"Expression of vascular cell adhesion molecule-1 (VCAM-1) by human brain microvessel endothelial cells in primary culture","volume":"49","author":"Wong","year":"1995","journal-title":"Microvasc Res"},{"key":"2023032406065853700_jlb10171-cit-0051","first-page":"1309","article-title":"Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system","volume":"136","author":"Sobel","year":"1990","journal-title":"Am J Pathol"},{"key":"2023032406065853700_jlb10171-cit-0052","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-4690-7-30","article-title":"Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection","volume":"7","author":"Gras","year":"2010","journal-title":"Retrovirology"},{"key":"2023032406065853700_jlb10171-cit-0053","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/QAI.0b013e318042e1ee","article-title":"Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors","volume":"45","author":"Tozzi","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2023032406065853700_jlb10171-cit-0054","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13365-014-0279-x","article-title":"Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND)","volume":"20","author":"Ndhlovu","year":"2014","journal-title":"J Neurovirol"},{"key":"2023032406065853700_jlb10171-cit-0055","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1086\/651482","article-title":"Prevention of HIV infection among injection drug users in resource-limited settings","volume":"3","author":"Vlahov","year":"2010","journal-title":"Clin Infect Dis 50 Suppl"},{"key":"2023032406065853700_jlb10171-cit-0056","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.addbeh.2017.10.018","article-title":"Trends and key correlates of prescription opioid injection misuse in the United States","volume":"78","author":"Jones","year":"2017","journal-title":"Addict Behav"},{"key":"2023032406065853700_jlb10171-cit-0057","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1515195","article-title":"HIV infection linked to injection use of oxymorphone in Indiana, 2014\u20132015","volume":"375","author":"Peters","year":"2016","journal-title":"N Engl J Med"},{"key":"2023032406065853700_jlb10171-cit-0058","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/infdis\/jix307","article-title":"Detailed transmission network analysis of a large opiate-driven outbreak of HIV infection in the United States","volume":"216","author":"Campbell","year":"2017","journal-title":"J Infect Dis"},{"key":"2023032406065853700_jlb10171-cit-0059","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0022-3565(24)36668-6","article-title":"Activation of mu opioid receptors inhibits microglial cell chemotaxis","volume":"281","author":"Chao","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"2023032406065853700_jlb10171-cit-0060","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/CDLI.7.5.719-723.2000","article-title":"Detection and function of opioid receptors on cells from the immune system","volume":"7","author":"Bidlack","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"2023032406065853700_jlb10171-cit-0061","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1006\/bbrc.1995.2709","article-title":"Mu opioid receptor gene expression in immune cells","volume":"216","author":"Chuang","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"2023032406065853700_jlb10171-cit-0062","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/0006-2952(80)90431-1","article-title":"Stereoselective muscarinic acetylcholine and opiate receptiors in human phagocytic leukocytes","volume":"29","author":"Lopker","year":"1980","journal-title":"Biochem Pharmacol"},{"key":"2023032406065853700_jlb10171-cit-0063","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0014-5793(95)00766-3","article-title":"Identification of kappa- and delta-opioid receptor transcripts in immune cells","volume":"369","author":"Gaveriaux","year":"1995","journal-title":"FEBS Lett"},{"key":"2023032406065853700_jlb10171-cit-0064","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1749-6632.2000.tb06324.x","article-title":"C-C and C-X-C chemokines trigger firm adhesion of monocytes to vascular endothelium under flow conditions","volume":"902","author":"Luscinskas","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"2023032406065853700_jlb10171-cit-0065","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/19546","article-title":"MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions","volume":"398","author":"Gerszten","year":"1999","journal-title":"Nature"},{"key":"2023032406065853700_jlb10171-cit-0066","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw224","article-title":"Altered monocyte and endothelial cell adhesion molecule expression is linked to vascular inflammation in human immunodeficiency virus infection","volume":"3","author":"Kulkarni","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2023032406065853700_jlb10171-cit-0067","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10739680802425195","article-title":"Role of alpha4beta1 integrins in chemokine-induced monocyte arrest under conditions of shear stress","volume":"16","author":"Hyduk","year":"2009","journal-title":"Microcirculation"},{"key":"2023032406065853700_jlb10171-cit-0068","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0304-3940(94)90450-2","article-title":"ICAM-1 expression on human brain microvascular endothelial cells","volume":"168","author":"Hess","year":"1994","journal-title":"Neurosci Lett"},{"key":"2023032406065853700_jlb10171-cit-0069","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2990.1997.tb01187.x","article-title":"Expression of cell adhesion molecules by microvascular endothelial cells in the cortical and subcortical regions of the normal human brain: an immunohistochemical analysis","volume":"23","author":"Navratil","year":"1997","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2023032406065853700_jlb10171-cit-0070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0165-5728(97)00036-2","article-title":"Selective expression of adhesion molecules on human brain microvascular endothelial cells","volume":"76","author":"Stins","year":"1997","journal-title":"J Neuroimmunol"},{"key":"2023032406065853700_jlb10171-cit-0071","doi-asserted-by":"crossref","first-page":"a004994","DOI":"10.1101\/cshperspect.a004994","article-title":"Integrin structure, activation, and interactions","volume":"3","author":"Campbell","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2023032406065853700_jlb10171-cit-0072","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1034\/j.1600-065X.2002.18604.x","article-title":"Rapid leukocyte integrin activation by chemokines","volume":"186","author":"Laudanna","year":"2002","journal-title":"Immunol Rev"},{"key":"2023032406065853700_jlb10171-cit-0073","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-1759(02)00417-9","article-title":"Detecting rapid and transient upregulation of leukocyte integrin affinity induced by chemokines and chemoattractants","volume":"273","author":"Chan","year":"2003","journal-title":"J Immunol Methods"},{"key":"2023032406065853700_jlb10171-cit-0074","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1038\/emboj.2011.333","article-title":"Regulation of integrin affinity on cell surfaces","volume":"30","author":"Schurpf","year":"2011","journal-title":"EMBO J"},{"key":"2023032406065853700_jlb10171-cit-0075","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/10739680600776062","article-title":"The p110delta isoform of PI3K differentially regulates beta1 and beta2 integrin-mediated monocyte adhesion and spreading and modulates diapedesis","volume":"13","author":"Ferreira","year":"2006","journal-title":"Microcirculation"},{"key":"2023032406065853700_jlb10171-cit-0076","doi-asserted-by":"crossref","first-page":"32314","DOI":"10.1074\/jbc.M113.501668","article-title":"How natalizumab binds and antagonizes alpha4 integrins","volume":"288","author":"Yu","year":"2013","journal-title":"J Biol Chem"},{"key":"2023032406065853700_jlb10171-cit-0077","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.20858","article-title":"Immune surveillance in multiple sclerosis patients treated with natalizumab","volume":"59","author":"Stuve","year":"2006","journal-title":"Ann Neurol"},{"key":"2023032406065853700_jlb10171-cit-0078","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrneurol.2016.110","article-title":"Myeloid cells - targets of medication in multiple sclerosis","volume":"12","author":"Mishra","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"2023032406065853700_jlb10171-cit-0079","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nn.4475","article-title":"The role of peripheral immune cells in the CNS in steady state and disease","volume":"20","author":"Prinz","year":"2017","journal-title":"Nat Neurosci"},{"key":"2023032406065853700_jlb10171-cit-0080","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archneurol.2010.161","article-title":"Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided","volume":"67","author":"Warnke","year":"2010","journal-title":"Arch Neurol"},{"key":"2023032406065853700_jlb10171-cit-0081","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ana.24148","article-title":"JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis","volume":"75","author":"Chalkias","year":"2014","journal-title":"Ann Neurol"},{"key":"2023032406065853700_jlb10171-cit-0082","doi-asserted-by":"crossref","first-page":"16555","DOI":"10.1074\/jbc.M009068200","article-title":"Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis","volume":"276","author":"Ashida","year":"2001","journal-title":"J Biol Chem"},{"key":"2023032406065853700_jlb10171-cit-0083","doi-asserted-by":"crossref","first-page":"H2584","DOI":"10.1152\/ajpheart.00349.2002","article-title":"Role of endothelial MCP-1 in monocyte adhesion to inflamed human endothelium under physiological flow","volume":"283","author":"Maus","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2023032406065853700_jlb10171-cit-0084","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/jlb.61.4.529","article-title":"MCP-1-mediated chemotaxis requires activation of non-overlapping signal transduction pathways","volume":"61","author":"Yen","year":"1997","journal-title":"J Leukoc Biol"},{"key":"2023032406065853700_jlb10171-cit-0085","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.4049\/jimmunol.1302647","article-title":"Buprenorphine decreases the CCL2-mediated chemotactic response of monocytes","volume":"194","author":"Carvallo","year":"2015","journal-title":"J Immunol"},{"key":"2023032406065853700_jlb10171-cit-0086","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/brain\/awh655","article-title":"Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis","volume":"129","author":"Mahad","year":"2006","journal-title":"Brain"},{"key":"2023032406065853700_jlb10171-cit-0087","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tips.2005.11.002","article-title":"The expression and function of chemokines involved in CNS inflammation","volume":"27","author":"Ubogu","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"2023032406065853700_jlb10171-cit-0088","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1044-5323(02)00125-2","article-title":"The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)","volume":"15","author":"Mahad","year":"2003","journal-title":"Semin Immunol"},{"key":"2023032406065853700_jlb10171-cit-0089","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/icb.2014.15","article-title":"Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis","volume":"92","author":"Chuluundorj","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"2023032406065853700_jlb10171-cit-0090","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.4049\/jimmunol.1501960","article-title":"Pivotal role for CD16+ monocytes in immune surveillance of the central nervous system","volume":"196","author":"Waschbisch","year":"2016","journal-title":"J Immunol"},{"key":"2023032406065853700_jlb10171-cit-0091","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1084\/jem.20132477","article-title":"Differential roles of microglia and monocytes in the inflamed central nervous system","volume":"211","author":"Yamasaki","year":"2014","journal-title":"J Exp Med"},{"key":"2023032406065853700_jlb10171-cit-0092","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40169-014-0040-3","article-title":"Clinical significance of monocyte heterogeneity","volume":"4","author":"Stansfield","year":"2015","journal-title":"Clin Transl Med"},{"key":"2023032406065853700_jlb10171-cit-0093","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tcm.2008.11.004","article-title":"Monocyte-endothelial cell interactions in the development of atherosclerosis","volume":"18","author":"Mestas","year":"2008","journal-title":"Trends Cardiovasc Med"},{"key":"2023032406065853700_jlb10171-cit-0094","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S0376-8716(03)00061-9","article-title":"Safety and health policy considerations related to the use of buprenorphine\/naloxone as an office-based treatment for opiate dependence","volume":"70","author":"Bridge","year":"2003","journal-title":"Drug Alcohol Depend"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2FJLB.3HI0118-015R","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/JLB.3HI0118-015R","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/JLB.3HI0118-015R","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/104\/6\/1049\/49558194\/jlb10171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/104\/6\/1049\/49558194\/jlb10171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T18:21:19Z","timestamp":1751653279000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/104\/6\/1049\/6935496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,23]]},"references-count":94,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,5,23]]},"published-print":{"date-parts":[[2018,11,27]]}},"URL":"https:\/\/doi.org\/10.1002\/jlb.3hi0118-015r","relation":{},"ISSN":["1938-3673","0741-5400"],"issn-type":[{"value":"1938-3673","type":"electronic"},{"value":"0741-5400","type":"print"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,5,23]]}}}